Duolingo, Inc. - Class A (DUOL)
Live price chart, market sentiment, and community perspectives for Duolingo, Inc. - Class A (NASDAQ: DUOL).
Live price chart, market sentiment, and community perspectives for Duolingo, Inc. - Class A (NASDAQ: DUOL).
On our desk, the divide on DUOL is stark. While crowd sentiment spans wildly from 6% bullish on news channels to 46% on X, Wall Street maintains a conservative consensus Hold with an average 12-month target around $121.79. D.A. Davidson's recent upgrade to a $160 target provides a notable outlier, but overall valuation skepticism persists following the recent post-earnings volatility.
Reviewing the Q2 2026 numbers, the core operational momentum looks solid with daily active users up 23% to 58.7 million and paid subscribers growing 17% to 12.7 million. However, net income dropped 26% to $33.2 million, and Adjusted EBITDA margins compressed to 25.9% from 31.2%. The fundamental question is how quickly user growth translates into sustainable, high-margin monetization.
When analyzing historical earnings quality for DUOL, analysts must look past headline figures. For instance, out of $414.1 million in net income reported in the annual filing, $256.7 million stemmed from a one-time tax entry. Evaluating core operational billing velocity versus reported revenue is essential for accurate cash flow modeling.
From a balance sheet perspective, DUOL remains fortified with zero debt and roughly $1.2 billion in cash and short-term investments. This robust liquidity profile provides management ample runway to execute product experimentation and retention initiatives like the Streak Revival campaign without near-term capital constraints.
Watching the market reaction to Q2 earnings, shares dropped 11% initially due to cautious full-year bookings guidance and lighter Q3 revenue forecasts of about $302 million against the $303.9 million consensus. Even with an EPS beat of $0.66 versus $0.60 expected, investors punished the stock for slowing incremental billings growth relative to user expansion.
Explore plasma cleansing, somatic organ swaps, and BCI.